SCHEMBL1784133

SCHEMBL1784133

O=Cc1ccc2oc3ccccc3c(=O)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.62
KDM4E B2RXH2 2/20 0.62
MAPT P10636 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
ALDH1A1 P00352 1/20 0.62
GLA P06280 1/20 0.62
CYP3A4 P08684 1/20 0.62
HPGD P15428 1/20 0.62
PGAM1 P18669 1/20 0.62
CASP1 P29466 1/20 0.62
CASP7 P55210 1/20 0.62
HSD17B10 Q99714 1/20 0.62
TTR P02766 2/20 0.55
NPC1 O15118 6/20 0.54
RAB9A P51151 5/20 0.54
CASP3 P42574 2/20 0.54
SENP7 Q9BQF6 2/20 0.54
SENP6 Q9GZR1 2/20 0.54
SENP8 Q96LD8 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1784418 0.90 MAOA (0.62) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL1420897 0.87 MAPT (0.53) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL11575950 0.85 MAOA (0.60) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL8715997 0.81 CYP2A6 (0.50) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL2533931 0.80 MAPT (0.54) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
Xanthone SCHEMBL41161 0.79 MAOA (1.00) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
Xanthone SCHEMBL29398266 0.79 MAOA (1.00) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
Xanthone SCHEMBL29358061 0.79 MAOA (1.00) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
Xanthone SCHEMBL2354794 0.79 MAOA (1.00) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL11809439 0.79 ALDH1A1 (0.63) MAOAKDM4EMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8323750-B2 Method of ultraviolet light assisted surface modification and product having a surface formed by this method BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) 2012-12-04 US disclosed
US-20110124766-A1 METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124766-A1 METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD XPA, CYBA, PROC MAOA 34/4885KDM4E 1160/4885MAPT 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.